Deutsche Märkte öffnen in 3 Stunden 2 Minuten

Becton, Dickinson and Company (BDX)

NYSE - NYSE Verzögerter Preis. Währung in USD
Zur Watchlist hinzufügen
228,40-8,43 (-3,56%)
Börsenschluss: 04:00PM EDT
229,90 +1,50 (+0,66%)
Nachbörse: 07:56PM EDT

Becton, Dickinson and Company

1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
201 847 6800
https://www.bd.com

Sektor(en)Healthcare
BrancheMedical Instruments & Supplies
Vollzeitmitarbeiter75.000

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Thomas E. Polen Jr.Pres, CEO & Chairman3,69MN/A1973
Mr. Christopher DelOreficeExec. VP & CFO511,65kN/A1971
Mr. Samrat S. Khichi Esq.Exec. VP of Corp. Devel., Public Policy & Regulatory Affairs and Gen. Counsel1,46MN/A1967
Mr. Thomas J. SpoerelSr. VP, Controller & Chief Accounting OfficerN/AN/A1978
Ms. Elizabeth McCombsExec. VP & Chief Technology OfficerN/AN/A1976
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.Sr. VP, Chief Scientific Officer & Co-Chair of Scientific Advisory BoardN/AN/AN/A
Ms. Denise FlemingExec. VP of Technology & Global Services and Chief Information OfficerN/AN/AN/A
Ms. Francesca M. DeMartinoSr. VP & Head of Investor RelationsN/AN/AN/A
Michelle QuinnSr. VP and Chief Ethics & Compliance OfficerN/AN/AN/A
Troy KirkpatrickVP of PRN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2021 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Corporate Governance

Becton, Dickinson and Companys ISS Governance QualityScore, Stand 1. Oktober 2022, lautet 10. Die grundlegenden Scores sind Audit: 8, Vorstand: 9, Shareholderrechte: 10, Kompensation: 10.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.